They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

NBC Medical Analyst and pulmonologist Dr. Vin Gupta reacts to HHS Secretary Robert F. Kennedy Jr.'s announcement to cut $500 ...

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...

Fox News senior medical analyst Dr. Marc Siegel reflects on his interview with NIH Director Dr. Jay Bhattacharya addressing ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

If you want to understand why Secretary of Health and Human Services Robert F. Kennedy Jr. has halted $500 million in funding ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...